InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by IGUCHI KIMI, Chief Financial Officer. Director active across 1 companies, notably Sage Therapeutics, Inc.. Cumulatively, 8 filings have been logged. The latest transaction was disclosed on 17 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€5,3804,500 shares@ €1.195645.7% of flow
Common Stock
SEC:0001562180-22-001627·
€5,3804,500 shares@ €1.195622.9% of flow
Common Stock
SEC:0001562180-22-001627:0·
€3,0152,500 shares@ €1.206125.6% of flow
Common Stock
SEC:0001562180-21-007224·
€3,0152,500 shares@ €1.206112.8% of flow
Common Stock
SEC:0001562180-21-007224:0·
03,800 shares0
Common Stock
SEC:0001562180-21-006600·
03,800 shares0
Common Stock
SEC:0001562180-21-006600:0·
€3,3643,000 shares@ €1.121528.6% of flow
Common Stock
SEC:0001562180-21-004337·
€3,3643,000 shares@ €1.121514.3% of flow
Common Stock
SEC:0001562180-21-004337:0·
8 of 8 declarations
About IGUCHI KIMI
Kimi Iguchi is the CFO & Treasurer at Sage Therapeutics, Inc. In this role, she oversees the financial management of the company and ensures compliance with financial regulations. Her expertise in finance is crucial for supporting the company's growth and strategy.
